does tirzepatide affect bone density Weight loss induced loss: mechanism of action and clinical implications Frontiers | Bone mineral density

Recent studies have demonstrated that switching from DPP4-inhibitor to oral semaglutide helps achieve HbA1c targets with less use of additional glucose-lowering medication and offers the potential for a greater reduction in BW, despite a slight risk of gastrointestinal symptoms [30, 31]

Van Poppel, H

Sex-specific alterations in NAD+ metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC-MS

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to control blood sugar levels and reduce the risk of heart disease